Albert Cupo

Cornell University — United States

Immunology and Microbiology · Life Sciences

42h-index10.1kcitations69works10.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(57), Monoclonal and Polyclonal Antibodies Research(34), Glycosylation and Glycoproteins Research(19), Immune Cell Function and Interaction(15), HIV/AIDS drug development and treatment(9)

Publications69 total

HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trial
Nature Communications·2025Open Access
A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers
Journal of Virology·2025· 1 citedOpen Access
Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques
2025Open Access
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science·2025· 22 citedOpen Access
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology·2024· 27 citedOpen Access
Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
Science Immunology·2024· 15 citedOpen Access
Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques
2023· 2 citedOpen Access
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
PLoS ONE·2023Open Access
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
PLoS Medicine·2023· 7 citedOpen Access
SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia
2022· 1 citedOpen Access
Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody
Cell Reports Medicine·2022· 13 citedOpen Access
Predictors of Nonseroconversion after SARS-CoV-2 Infection
Emerging infectious diseases·2021· 66 citedOpen Access
Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
Pathogens and Immunity·2021· 130 citedOpen Access
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Cell Reports·2021· 61 citedOpen Access
Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
2021· 34 citedOpen Access
Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin
Journal of Virology·2019· 37 citedOpen Access
SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers
Journal of Virology·2019· 8 citedOpen Access
Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells
PLoS ONE·2019· 25 citedOpen Access
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
Journal of Pharmaceutical Sciences·2019· 21 citedOpen Access
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers <i>In Vitro</i>
Journal of Virology·2018· 45 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

John P. Moore(46), Rogier W. Sanders(38), Andrew B. Ward(36), Ian A. Wilson(34), Per Johan Klasse(25), Jean‐Philippe Julien(21), Gabriel Ozorowski(19), Anila Yasmeen(18), Dennis R. Burton(15), Thomas J. Ketas(13), Jeong Hyun Lee(12), Max Crispin(11), Rajesh P. Ringe(11), Ronald Derking(10), Helen J. Kim(9), Michael Golabek(9), Marit J. van Gils(8), Robyn L. Stanfield(8), Reza Khayat(7), Andre J. Marozsan(7)